{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:15:10Z","timestamp":1792199710459,"version":"4.4.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The intestinal barrier is a critical interface between the host and the external environment, and growing evidence indicates that bidirectional crosstalk between the gut microbiota and the intestinal barrier is a key determinant of intestinal and systemic health. Disruption of this interaction has been implicated in the development of multiple chronic non-communicable diseases, including inflammatory, metabolic, neurodegenerative, and immune-mediated conditions. However, previous reviews have often examined gut microbiota or intestinal barrier dysfunction separately, with less emphasis on their bidirectional interaction as an integrated mechanistic and public health framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aims to synthesize current mechanistic advances in gut microbiota\u2013intestinal barrier crosstalk, evaluate its relevance across major disease domains, and examine its potential implications for chronic disease prevention and public health practice. In particular, this review highlights the gut microbiota\u2013intestinal barrier axis as a unifying framework linking microbial metabolism, mucosal homeostasis, systemic inflammation, and prevention-oriented health strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a structured review of recent studies published between 2019 and 2025 in PubMed, Scopus, and Web of Science, with emphasis on both foundational and emerging evidence. The review focused on microbiota-derived metabolites, epithelial junction integrity, mucosal immune regulation, disease-associated barrier dysfunction, and microbiota-targeted interventions. Evidence from mechanistic, preclinical, and clinical studies was integrated to identify major advances, translational opportunities, and current limitations in the field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Current evidence indicates that gut microbiota regulate intestinal barrier integrity through metabolites such as short-chain fatty acids (SCFAs), indole derivatives, and bile acids, which influence tight junction expression, mucin production, epithelial repair, and mucosal immune balance. Conversely, barrier dysfunction may promote microbial translocation, endotoxemia, and chronic low-grade inflammation, thereby contributing to diseases such as inflammatory bowel disease, type 2 diabetes, metabolic-associated fatty liver disease, and neurodegenerative or neuropsychiatric disorders. Microbiota-targeted interventions, including prebiotics, probiotics, dietary approaches, and fecal microbiota transplantation, have shown potential to restore barrier-related homeostasis. However, the current evidence remains constrained by heterogeneity in study design, incomplete causal validation, inconsistent clinical outcomes, and limited standardization of intervention strategies, all of which restrict clinical translation and large-scale public health implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The gut microbiota\u2013intestinal barrier axis is an important determinant of health and disease and may represent a promising target for future prevention-oriented strategies. By integrating mechanistic evidence with disease relevance, translational limitations, and public health perspectives, this review provides a more coherent framework for understanding microbiota\u2013barrier crosstalk. Future research should prioritize causal validation, standardized methodologies, and equitable implementation pathways to support the development of scalable preventive and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1777910","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:34:24Z","timestamp":1777872864000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Gut microbiota\u2013intestinal barrier crosstalk: mechanistic advances, disease relevance, and public health implications"],"prefix":"10.3389","volume":"14","author":[{"given":"Changmei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pathophysiology & Pharmacology, Medicine & Technology College of Zunyi Medical University","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1762284","DOI":"10.3389\/fimmu.2025.1762284","article-title":"Editorial: The role of bioactive compounds and nutrients in intestinal mucosal immunity, liver and vascular inflammation","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1717638","DOI":"10.3389\/fcdhc.2025.1717638","article-title":"Gut and circulating microbiota in the pathophysiology and clinical complications of diabetes","volume":"6","author":"Vasudevan","year":"2025","journal-title":"Front Clin Diabetes Healthcare"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1691238","DOI":"10.3389\/fmicb.2025.1691238","article-title":"Editorial: Exploring the oral-gut microbiome interactions: pathways to therapeutic strategies and implications for systemic health","volume":"16","author":"Lan","year":"2025","journal-title":"Front Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e70040","DOI":"10.1002\/imt2.70040","article-title":"Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4+ T cell differentiation","volume":"4","author":"Xing","year":"2025","journal-title":"iMeta"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1721724","DOI":"10.3389\/fimmu.2025.1721724","article-title":"Editorial: Mucosal microbiota immunomodulation of the gut-lung axis","volume":"16","author":"Moon","year":"2025","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"109780","DOI":"10.1016\/j.envint.2025.109780","article-title":"Mechanisms of metabolic-associated fatty liver disease induced by 48-week PCB138 exposure and theabrownin intervention","volume":"181","author":"Han","year":"2025","journal-title":"Environ Int"},{"key":"ref10","first-page":"229","volume-title":"Organ System Crosstalk in Critical Illness","author":"Godi","year":"2025"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"C440","DOI":"10.1152\/ajpcell.00411.2025","article-title":"Gut microbiome promotes succinate-induced ulcerative colitis by enhancing glycolysis through SUCNR1\/NF-\u03baB signaling pathway","volume":"329","author":"Shan","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1705365","DOI":"10.3389\/fimmu.2025.1705365","article-title":"Editorial: Understanding the impact of microbes on tumor progression and prevention: unveiling new avenues for cancer therapy","volume":"16","author":"Somani","year":"2025","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12935-025-03840-9","article-title":"Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer","volume":"25","author":"Goyal","year":"2025","journal-title":"Cancer Cell Int"},{"key":"ref14","article-title":"Exploring the gut-kidney axis in chronic kidney disease: In vitro insights into interorgan crosstalk","author":"Giordano","year":"2025"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41467-020-19931-2","article-title":"Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system","volume":"11","author":"Chevalier","year":"2020","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S2468-1253(22)00241-2","article-title":"The intestinal barrier in disorders of the central nervous system","volume":"8","author":"Pellegrini","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"01","DOI":"10.58372\/2835-6276.1336","article-title":"Stem cell and peptide-based therapeutics for gut diseases: restoring the stomach and intestinal mucosa through microbiome and mitochondrial modulation","volume":"4","author":"Chan","year":"2025","journal-title":"Am J Med Clin Res Rev"},{"key":"ref18","article-title":"The total flavonoids from Meconopsis gakyidiana mitigate alcoholic liver disease via modulating the gut microbiota-AhR axis and restoring intestinal integrity","author":"Yang","year":"2025","journal-title":"SSRN"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.35946\/arcr.v38.2.02","article-title":"Alcohol and gut-derived inflammation","volume":"38","author":"Bishehsari","year":"2017","journal-title":"Alcohol Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-69","DOI":"10.12688\/f1000research.20510.1","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","volume":"9","author":"Fasano","year":"2020","journal-title":"F1000Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-82","article-title":"Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals","volume":"27","author":"Asnicar","year":"2021","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The integrative human microbiome project","volume":"569","year":"2019","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","article-title":"Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts","volume":"14","author":"Ning","year":"2023","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","article-title":"Longitudinal multi-omics of host-microbe dynamics in prediabetes","volume":"569","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1651581","DOI":"10.3389\/fcimb.2025.1651581","article-title":"The effect of Ganpichengpi diarrhea and Tongxie Yaofang intervention on the intestinal mucosal microbiota and neurochemical substances","volume":"15","author":"Long","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1628488","DOI":"10.3389\/fcimb.2025.1628488","article-title":"Pingwei powder alleviates high-fat diet-induced colonic inflammation by modulating microbial metabolites SCFAs","volume":"15","author":"Liu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwaf017","article-title":"Pasteurized Akkermansia muciniphila promotes GP2 expression in microfold cells and facilitates Salmonella infection","author":"Zhang","year":"2025","journal-title":"Protein Cell"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1608271","DOI":"10.3389\/fcimb.2025.1608271","article-title":"Synergistic treatment of sodium propionate and Sishen pill for diarrhea mice with kidney-yang deficiency syndrome","volume":"15","author":"Guo","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1581166","DOI":"10.3389\/fmicb.2025.1581166","article-title":"Editorial: Rodent model organisms: therapeutic treatments and drugs interaction with the gut microbiome","volume":"16","author":"Bezirtzoglou","year":"2025","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1570451","DOI":"10.3389\/fmicb.2025.1570451","article-title":"Editorial: Exploring the influence of gut microbiome on human health: mechanistic insights from pig models","volume":"16","author":"Meurens","year":"2025","journal-title":"Front Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease","volume":"9","author":"Zuo","year":"2018","journal-title":"Front Microbiol"},{"key":"ref35","volume-title":"Exploring the Gut\u2013Kidney Axis in CKD: In Vitro Perspectives","author":"Giordano","year":"2025"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut\u2013brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"eaau8317","DOI":"10.1126\/sciadv.aau8317","article-title":"The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice","volume":"5","author":"Zheng","year":"2019","journal-title":"Sci Adv"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s40263-016-0370-3","article-title":"May the force be with you: the light and dark sides of the microbiota-gut-brain Axis in neuropsychiatry","volume":"30","author":"Sherwin","year":"2016","journal-title":"CNS Drugs"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","article-title":"The neuroactive potential of the human gut microbiota in quality of life and depression","volume":"4","author":"Valles-Colomer","year":"2019","journal-title":"Nat Microbiol"},{"key":"ref40","article-title":"Total flavonoids from Meconopsis gakyidiana improve alcoholic liver via microbiota-AhR axis","author":"Yang","year":"2025","journal-title":"SSRN"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota-brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref42","first-page":"350","article-title":"Microbiota-modulating therapeutics for gut diseases","volume-title":"Am J Med Clin Res Rev","author":"Chan","year":"2025"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1777910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:34:26Z","timestamp":1777872866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1777910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2026.1777910"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1777910","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1777910"}}